The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Open accessAbstract
Soluble oligomers of amyloid beta (Abeta) play a role in the memory impairment characteristic of Alzheimer's disease. Acting as pathogenic ligands, Abeta oligomers bind to particular synapses and perturb their function, morphology, and maintenance. Events that occur shortly after oligomer binding have been investigated here in live hippocampal neurons by single particle tracking of quantum dot-labeled oligomers and synaptic proteins. Membrane-attached oligomers initially move freely, but their diffusion is hindered markedly upon accumulation at synapses. Concomitantly, individual metabotropic glutamate receptors (mGluR5) manifest strikingly reduced lateral diffusion as they become aberrantly clustered. This clustering of mGluR5 elevates intracellular calcium and causes synapse deterioration, responses prevented by an mGluR5 antagonist. As expected, clustering by artificial crosslinking also promotes synaptotoxicity. These results reveal a mechanism whereby Abeta oligomers induce the abnormal accumulation and overstabilization of a glutamate receptor, thus providing a mechanistic and molecular basis for Abeta oligomer-induced early synaptic failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Aβ oligomers can drive additional vicious cycles by stimulating metabotropic glutamate receptor 5 (mGluR5)146,147, which activates feedforward Ca2+–cAMP signaling and drive tau phosphorylation (Fig. 5, brown).”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [146]
In the citing paper
“Aβ binds to α7 nicotinic acetylcholine receptors (α7 nAChRs) and to metabotropic glutamate receptors, in particular mGluR5 [31–33].”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [32]
In the citing paper
“ADDL binding to synapses displays saturable kinetics (Renner et al., 2010)”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“Double-labeling with synaptophysin or FM463 establishes this localization to be at functional synapses (Renner et al., 2010).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“single particle tracking of quantum dot-labeled Aβ oligomers has demonstrated the participation of metabotropic glutamate receptors (mGluR5) in oligomer binding and clustering at synapses (Renner et al., 2010).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“Initially, Aβ oligomers diffused as if bound to an untethered protein. Within minutes, however, movement slowed and oligomers became immobilized, typically at active synapses labeled with FM4-64. The synaptic trapping of oligomers was accompanied by co-clustering and immobilization of mGluR5 metabotropic glutamate receptors.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“protection also is afforded by antagonists of metabotropic mGluR5 receptors (Rammes et al., 2011; Renner et al., 2010; Wang et al., 2004).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
In the citing paper
“the recent finding that mGluR5 is implicated in the toxic clustering of Aβ oligomers at synapses and the ensuing aberrant calcium signaling (Renner et al., 2010) suggests that selective mGluR5 inhibitors may hold potential to block oligomer-induced synapse dysfunction.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Renner et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Diffusion Dynamics of Glycine Receptors Revealed by Single-Quantum Dot Tracking
Dahan, M., Lévi, S., Luccardini, C., Rostaing, P., Riveau, B., & Triller, A. (2003) · Science · doi:10.1126/science.1088525 · Cited by 1,465
Self-citationAstrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,371
Lacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188
Self-citation
Cited by
Sorted by citations
Items 101–200 of 468
Spurrier, J., Nicholson, L., Fang, X. T., Stoner, A. J., Toyonaga, T., Holden, D., Siegert, T. R., Laird, W., Allnutt, M. A., Chiasseu, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi8593 · Cited by 114
Bao, F., Wicklund, L., Lacor, P. N., Klein, W. L., Nordberg, A. K., & Marutle, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.003 · Cited by 112
Self-citationRole of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease
Александровна, П. Е., & Борисович, Б. И. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00029 · Cited by 110
Shrivastava, A. N., Kowalewski, J. M., Renner, M. L., Bousset, L., Koulakoff, A., Melki, R., Giaume, C., & Triller, A. (2013) · Glia · doi:10.1002/glia.22548 · Cited by 114
Self-citationDysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
Александровна, П. Е., Pchitskaya, E. I., & Борисович, Б. И. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7506 · Cited by 106
Astrocytes in Alzheimer's Disease: Emerging Roles in Calcium Dysregulation and Synaptic Plasticity
Vincent, A. J., Gasperini, R., Foa, L. C., & Small, D. H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101089 · Cited by 106
Chebaro, Y., Jiang, P., Zang, T., Mu, Y., Nguyen, P. H., Mousseau, N., & Derreumaux, P. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2118778 · Cited by 102
Glutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances
Hu, N., Ondrejčák, T., & Rowan, M. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.013 · Cited by 99
Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
Klyubin, I. V., Cullen, W. K., Hu, N., & Rowan, M. J. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-25 · Cited by 105
Aloisi, E., Corf, K. L., Dupuis, J. P., Zhang, P., Ginger, M. R., Labrousse, V. F., Spatuzza, M., Haberl, M. G., Costa, L., Shigemoto, R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01191-2 · Cited by 98
Oh, S. J., Lee, H., Jeong, Y. J., Nam, K. R., Kang, K. J., Han, S. J., Lee, K. C., Lee, Y. J., & Choi, J. Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-72755-4 · Cited by 101
Dinamarca, M. C., Ríos, J. A., & Inestrosa, N. C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00464 · Cited by 105
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss
Birnbaum, J. H., Bali, J., Rajendran, L., Nitsch, R. M., & Tackenberg, C. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.160 · Cited by 101
Shrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 96
Self-citationNunes‐Tavares, N., Santos, L. E., Stutz, B., Brito‐Moreira, J., Klein, W. L., Ferreira, S. T., & Mello, F. G. D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321448 · Cited by 96
Self-citationSubsynaptic positioning of AMPARs by LRRTM2 controls synaptic strength
Ramsey, A. M., Tang, A., LeGates, T. A., Gou, X., Carbone, B. E., Thompson, S. M., Biederer, T., & Blanpied, T. A. (2021) · Science Advances · doi:10.1126/sciadv.abf3126 · Cited by 90
Ménard, C., & Quirion, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028666 · Cited by 98
Ménard, C., & Quirion, R. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00182 · Cited by 93
Therapeutic potential of mGluR5 targeting in Alzheimer's disease
Kumar, A., Dhull, D. K., & Mishra, P. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00215 · Cited by 93
Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. E. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 94
Amyloid-β-induced Synapse Damage Is Mediated via Cross-linkage of Cellular Prion Proteins
Bate, C., & Williams, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248724 · Cited by 93
Haas, L. T., Kostylev, M. A., & Strittmatter, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584342 · Cited by 91
Pathogenesis of Abeta Oligomers in Synaptic Failure
Sivanesan, S., Tan, A., & Rajadas, J. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310030011 · Cited by 85
Brody, A. H., & Strittmatter, S. M. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.09.007 · Cited by 89
Mimura, Y., Nishida, H., Nakajima, S., Tsugawa, S., Morita, S., Yoshida, K., Tarumi, R., Ogyu, K., Wada, M., Kurose, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.003 · Cited by 86
Synaptic dysfunction in early phases of Alzheimer's Disease
Pelucchi, S., Gardoni, F., Luca, M. D., & Marcello, E. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 95
Moreno-Castilla, P., Rodriguez-Duran, L. F., Guzman-Ramos, K., Barcenas-Femat, A., Escobar, M. L., & Bermudez-Rattoni, F. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.021 · Cited by 84
Pitt, J. E., Wilcox, K. C., Tortelli, V., Diniz, L. P., Oliveira, M. S., Dobbins, C., Yu, X., Nandamuri, S., Gomes, F. C. A., DiNunno, N., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0416 · Cited by 87
Self-citationPrion Protein as a Toxic Acceptor of Amyloid-β Oligomers
Purro, S. A., Nicoll, A. J., & Collinge, J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.020 · Cited by 81
Smith, L. M., Kostylev, M. A., Lee, S., & Strittmatter, S. M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006252 · Cited by 73
STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity
Александровна, П. Е., Pchitskaya, E. I., Speshilova, A. B., Alexandrov, S., Zhang, H., Власова, О. Л., & Борисович, Б. И. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0034-7 · Cited by 81
Therapeutic role of rifampicin in Alzheimer's disease
Yuluğ, B., Hanoğlu, L., Ozansoy, M., Isık, D., Kılıç, Ü., Kılıç, E., & Schabitz, W. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12637 · Cited by 81
Abd‐Elrahman, K. S., Albaker, A. B., de Souza, J. M., Ribeiro, F. M., Schlossmacher, M. G., Tiberi, M., Hamilton, A., & Ferguson, S. S. G. (2020) · Science Signaling · doi:10.1126/scisignal.abd2494 · Cited by 79
Alzheimer culprits: Cellular crossroads and interplay
Claeysen, S., Cochet, M., Donneger, R., Dumuis, A., Bockaert, J., & Giannoni, P. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.05.008 · Cited by 82
Fossati, S., Ghiso, J. A., & Rostagno, A. A. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.55 · Cited by 79
Haas, L. T., & Strittmatter, S. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720664 · Cited by 75
Translational Concepts of mGluR5 in Synaptic Diseases of the Brain
Piers, T. M., Kim, D. H., Kim, B. C., Regan, P. L., Whitcomb, D. J., & Cho, K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00199 · Cited by 80
Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs
Shrivastava, A. N., Bousset, L., Renner, M. L., Redeker, V., Savistchenko, J., Triller, A., & Melki, R. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.01.022 · Cited by 79
Self-citationEpilepsy and Alzheimer’s Disease: Potential mechanisms for an association
Giorgi, F. S., Saccaro, L. F., Busceti, C. L., Biagioni, F., & Fornai, F. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.009 · Cited by 80
Ji, Y., Han, J., Lee, N., Yoon, J.-H., Youn, K., Ha, H. J., Yoon, E., Kim, D. H., & Jun, M. (2020) · Molecules · doi:10.3390/molecules25215087 · Cited by 75
Caetano, F. A., Beraldo, F. H., Hajj, G. N. M., Guimaraes, A. L., Jürgensen, S., Wasilewska-Sampaio, A. P., Hirata, P. H. F., Souza, I., Machado, C. F., Wong, D. Y.-L., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07225.x · Cited by 74
Grochowska, K. M., Yuanxiang, P., Bär, J., Raman, R., Brugal, G. N., Sahu, G., Schweizer, M., Bikbaev, A. F., Schilling, S., Demuth, H., et al. (2017) · EMBO Reports · doi:10.15252/embr.201643519 · Cited by 75
Cell biology and dynamics of Neuronal Na+/K+-ATPase in health and diseases
Shrivastava, A. N., Triller, A., & Melki, R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.008 · Cited by 75
Self-citationMembrane Interactions and Toxicity by Misfolded Protein Oligomers
Gonzalez-Garcia, M., Fusco, G., & Simone, A. D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.642623 · Cited by 73
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
Abd‐Elrahman, K. S., & Ferguson, S. S. G. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-021821-091747 · Cited by 73
Overk, C., Cartier, A. E., Shaked, G. M., Rockenstein, E. M., Ubhi, K. K., Spencer, B. J., Price, D. L., Patrick, C., Desplats, P., & Masliah, E. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-18 · Cited by 73
RetractedFu, Y., Zhao, J., Atagi, Y., Nielsen, H. M., Liu, C.-C., Zheng, H., Shinohara, M., Kanekiyo, T., & Bu, G. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0099-y · Cited by 69
Hamilton, A., Zamponi, G. W., & Ferguson, S. S. G. (2015) · Molecular Brain · doi:10.1186/s13041-015-0107-0 · Cited by 72
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
Yan, R., Fan, Q., Zhou, J., & Vassar, R. J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.025 · Cited by 71
Bruno, V., Caraci, F., Copani, A., Matrisciano, F., Nicoletti, F., & Battaglia, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.044 · Cited by 73
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70
Vargas, L. M., Cerpa, W. F., Muñoz, F. J., Zanlungo, S., & Alvarez, A. R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.023 · Cited by 71
Disruption of neocortical histone H3 homeostasis by soluble Aβ: implications for Alzheimer's disease
Lithner, C. U., Lacor, P. N., Zhao, W.-Q., Mustafiz, T., Klein, W. L., Sweatt, J. D., & Hernandez, C. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.028 · Cited by 67
Self-citationSumoylation in Synaptic Function and Dysfunction
Schorova, L., & Martin, S. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00009 · Cited by 72
Beraldo, F. H., Ostapchenko, V. G., Caetano, F. A., Guimarães, A. L. S., Ferretti, G. D. S., Daude, N., Bertram, L. N., Nogueira, K. D. O. P. C., Silva, J. L., Westaway, D. A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738286 · Cited by 67
Jakaria, M., Park, S., Haque, M. E., Karthivashan, G., Kim, I., Ganesan, P., & Choi, D. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00307 · Cited by 71
Arizono, M., Bannai, H., Nakamura, K. M., Niwa, F., Enomoto, M., Matsuura, T., Miyamoto, A., Sherwood, M. W., Nakamura, T., & Mikoshiba, K. (2012) · Science Signaling · doi:10.1126/scisignal.2002498 · Cited by 67
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 64
PET imaging of mGluR5 in Alzheimer’s disease
Mecca, A. P., McDonald, J. W., Michalak, H. R., Godek, T. A., Harris, J. E., Pugh, E., Kemp, E. C., Chen, M.-K., Salardini, A., Nabulsi, N., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-0582-0 · Cited by 66
Impairments of glutamatergic synaptic transmission in Alzheimer’s disease
Zott, B., & Konnerth, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.013 · Cited by 66
Ding, Y. J., Zhao, J., Zhang, X., Wang, S., Viola, K. L., Chow, F. E., Zhang, Y., Lippa, C. F., Klein, W. L., & Gong, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01140 · Cited by 68
Self-citationThe neuronal insulin receptor in its environment
Gralle, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13909 · Cited by 64
Westmark, C. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.122 · Cited by 63
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
Cárdenas, A. M., Ardiles, Á. O., Barraza, N., Báez‐Matus, X., & Caviedes, P. A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.012 · Cited by 68
The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain
McDonald, J. M., Cairns, N. J., Taylor‐Reinwald, L., Holtzman, D. M., & Walsh, D. M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.041 · Cited by 61
Bradley, S. J., & Challiss, R. A. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.009 · Cited by 66
Martin, H. G. S., Lassalle, O., Brown, J. T., & Manzoni, O. J. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv031 · Cited by 63
Kempf, S. J., Moertl, S., Sepe, S., von Toerne, C., Hauck, S. M., Atkinson, M. J., Mastroberardino, P. G., & Tapio, S. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00114 · Cited by 59
Sánchez‐Rodríguez, I., Djebari, S., Temprano‐Carazo, S., Vega‐Avelaira, D., Jiménez‐Herrera, R., Iborra‐Lázaro, G., Yajeya, J., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14946 · Cited by 54
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
Padmanabhan, P., Kneynsberg, A., & Götz, J. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00531-y · Cited by 59
Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse
Schedin-Weiss, S., Caesar, I., Winblad, B., Blom, H., & Tjernberg, L. O. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0296-5 · Cited by 58
Paula-Lima, A. C., Adasme, T., & Hidalgo, C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5796 · Cited by 59
Sinnen, B. L., Bowen, A. B., Gibson, E. S., & Kennedy, M. J. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1603-16.2016 · Cited by 59
Pitt, J. E., Thorner, M. O., Brautigan, D. L., Larner, J., & Klein, W. L. (2012) · The FASEB Journal · doi:10.1096/fj.12-211896 · Cited by 58
Self-citationThe Concentration of Soluble Extracellular Amyloid-β Protein in Acute Brain Slices from CRND8 Mice
Waters, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015709 · Cited by 60
Rui, Y., & Zheng, J. Q. (2016) · Molecular Brain · doi:10.1186/s13041-016-0261-z · Cited by 57
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
Cantaut-Belarif, Y., Antri, M., Pizzarelli, R., Colasse, S., Vaccari, I., Soares, S., Renner, M., Dallel, R., Triller, A., & Bessis, A. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201607048 · Cited by 56
Self-citationVelasco, P. T., Heffern, M. C., Sebollela, A. S., Popova, I. A., Lacor, P. N., Lee, K. B., Sun, X., Tiano, B. N., Viola, K. L., Eckermann, A. L., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300122k · Cited by 57
Self-citationLiu, Y., Wang, S., Kan, J., Zhang, J., Zhou, L., Huang, Y., & Zhang, Y. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191101125530 · Cited by 56
Clustering of Tau fibrils impairs the synaptic composition of α3‐Na+/K+‐ATPase and AMPA receptors
Shrivastava, A. N., Redeker, V., Pieri, L., Bousset, L., Renner, M. L., Madiona, K., Mailhes‐Hamon, C., Coens, A., Buée, L., Hantraye, P., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201899871 · Cited by 62
Self-citationAmyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 59
Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., Fonov, V., Jia, J., Gauthier, S. G., Rosa‐Neto, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047905 · Cited by 55
Synaptic Compensatory Plasticity in Alzheimer’s Disease
Bhembre, N., Bonthron, C., & Opazo, P. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-23.2023 · Cited by 56
Gephyrin-Independent GABAAR Mobility and Clustering during Plasticity
Niwa, F., Bannai, H., Arizono, M., Fukatsu, K., Triller, A., & Mikoshiba, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036148 · Cited by 53
Self-citationVEGF counteracts amyloid-β-induced synaptic dysfunction
Martin, L., Bouvet, P., Chounlamountri, N., Watrin, C., Besançon, R., Pinatel, D., Meyronet, D., Honnorat, J., Buisson, A., Salin, P. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109121 · Cited by 52
Taniguchi, K., Yamamoto, F., Amano, A., Tamaoka, A., Sanjo, N., Yokota, T., Kametani, F., & Araki, W. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.03.001 · Cited by 57
Cellular Prion Protein as a Therapeutic Target in Alzheimer's Disease
Laurén, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130950 · Cited by 55
Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain
Patel, A. N., & Jhamandas, J. H. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002134 · Cited by 51
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity
Goniotaki, D., Lakkaraju, A. K., Shrivastava, A. N., Bakirci, P., Sorce, S., Senatore, A., Marpakwar, R., Hornemann, S., Gasparini, F., Triller, A., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006733 · Cited by 52
Self-citationAbd‐Elrahman, K. S., Hamilton, A., Vasefi, M., & Ferguson, S. S. G. (2018) · Molecular Brain · doi:10.1186/s13041-018-0364-9 · Cited by 51
Sauerbeck, A. D., Gangolli, M., Reitz, S. J., Salyards, M. H., Kim, S., Hemingway, C., Gratuze, M., Makkapati, T., Kerschensteiner, M., Holtzman, D. M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.04.012 · Cited by 53
Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Zhang, X., Wang, D., Zhang, B., Zhu, J., Zhou, Z., & Cui, L. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.001 · Cited by 53
Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips
Ruiz, A., Joshi, P., Mastrangelo, R., Francolini, M., Verderio, C., & Matteoli, M. (2014) · Lab on a Chip · doi:10.1039/c4lc00174e · Cited by 49
How the shapes of seeds can influence pathology
Melki, R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.011 · Cited by 50
Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
Sellés, M. C., Oliveira, M. M., & Ferreira, S. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179925 · Cited by 51
mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent
Abd‐Elrahman, K. S., Hamilton, A., Albaker, A. B., & Ferguson, S. S. G. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00013 · Cited by 51
Metabotropic Glutamate Receptors in Central Nervous System Diseases
Golubeva, A. V., Moloney, R. D., O’Connor, R. M., Dinan, T. G., & Cryan, J. F. (2016) · Current Drug Targets · doi:10.2174/1389450116666150316224011 · Cited by 51
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Eph receptors: New players in Alzheimer's disease pathogenesis
Cissé, M., & Checler, F. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.028 · Cited by 50
Metadata
- Authors
- Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Northwestern University (US)
- Corresponding author
- Klein, William L.
- Triller, Antoine
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 66
- Issue
- 5
- Pages
- 739-754
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC3111138
- OpenAlex
- W2003655335
- Cited by
- 468
- References
- 62
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 23 · 2023: 14 · 2022: 26 · 2021: 34 · 2020: 38 · 2019: 25 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 38 · 2014: 31 · 2013: 30 · 2012: 44
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- National Institute on Aging (R01AG029460)
- National Institute of Neurological Disorders and Stroke (R01NS058894)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, mGluR5, metabotropic glutamate receptors, receptor clustering, synaptic dysfunction, synaptotoxicity, Alzheimer's disease, hippocampal neurons, single-particle tracking, quantum dots, intracellular calcium, receptor diffusion, receptor cross-linking
- MeSH terms
- Animals, Cells, Cultured, Extracellular Matrix, Neurons, Protein Binding, Synapses, Amyloid beta-Peptides, Rats, Sprague-Dawley, Receptors, Metabotropic Glutamate, Mice, Knockout, Mice, Rats, Protein Stability, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
